Compare PLUS & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLUS | WGS |
|---|---|---|
| Founded | 1990 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.7B |
| IPO Year | 1996 | 2020 |
| Metric | PLUS | WGS |
|---|---|---|
| Price | $91.11 | $97.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $120.71 |
| AVG Volume (30 Days) | 159.7K | ★ 476.4K |
| Earning Date | 05-21-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.20% | N/A |
| EPS Growth | 24.20 | ★ 62.37 |
| EPS | ★ 1.16 | N/A |
| Revenue | ★ $2,442,549,000.00 | $427,539,000.00 |
| Revenue This Year | $19.83 | $29.98 |
| Revenue Next Year | $4.36 | $25.92 |
| P/E Ratio | $78.58 | ★ N/A |
| Revenue Growth | 18.07 | ★ 39.97 |
| 52 Week Low | $69.35 | $32.21 |
| 52 Week High | $98.14 | $170.87 |
| Indicator | PLUS | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 56.66 | 64.70 |
| Support Level | $84.78 | $81.58 |
| Resistance Level | $93.33 | $140.83 |
| Average True Range (ATR) | 2.60 | 4.95 |
| MACD | 0.27 | 0.92 |
| Stochastic Oscillator | 68.12 | 68.59 |
ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.